153 related articles for article (PubMed ID: 18380352)
1. [Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate].
Strannegärd O; Thorén FB; Lundgren E
Lakartidningen; 2008 Feb 6-12; 105(6):358-61. PubMed ID: 18380352
[No Abstract] [Full Text] [Related]
2. Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha.
Konjević G; Jović V; Radulović S; Jelić S; Dzodić R; Spuzić I
Neoplasma; 2001; 48(3):175-81. PubMed ID: 11583285
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.
Neri B; Vannozzi L; Fulignati C; Pantaleo P; Pantalone D; Paoletti C; Perfetto F; Turrini M; Mazzanti R
Cancer Invest; 2006; 24(5):474-8. PubMed ID: 16939954
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma.
Rasi G; Terzoli E; Izzo F; Pierimarchi P; Ranuzzi M; Sinibaldi-Vallebona P; Tuthill C; Garaci E
Melanoma Res; 2000 Apr; 10(2):189-92. PubMed ID: 10803720
[No Abstract] [Full Text] [Related]
5. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
6. Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine.
Nashan D; Müller ML; Grabbe S; Wustlich S; Enk A
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1305-18. PubMed ID: 17958834
[TBL] [Abstract][Full Text] [Related]
7. Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes.
Håkansson A; Gustafsson B; Krysander L; Hjelmqvist B; Rettrup B; Håkansson L
Br J Cancer; 2001 Dec; 85(12):1871-7. PubMed ID: 11747328
[TBL] [Abstract][Full Text] [Related]
8. Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma.
Camp R; Lind DS; Hemming AW
J Hepatobiliary Pancreat Surg; 2002; 9(4):519-21. PubMed ID: 12483277
[TBL] [Abstract][Full Text] [Related]
9. Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.
Ridolfi L; Fiorentini G; Guida M; Michiara M; Freschi A; Aitini E; Ballardini M; Bichisao E; Ridolfi R;
Melanoma Res; 2009 Apr; 19(2):100-5. PubMed ID: 19262411
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of disseminated malignant melanoma. Results are promising, but toxicity is high].
Brunet A
Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):960-3. PubMed ID: 1303493
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma.
Xin Y; Huang Q; Zhang P; Yang M; Hou XY; Tang JQ; Zhang LZ; Jiang G
Medicine (Baltimore); 2016 Apr; 95(16):e3406. PubMed ID: 27100429
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary treatment of primary melanoma.
Yao K; Balch G; Winchester DJ
Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
[TBL] [Abstract][Full Text] [Related]
13. Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.
Danielli R; Fonsatti E; Calabrò L; Di Giacomo AM; Maio M
Ann N Y Acad Sci; 2012 Oct; 1270():8-12. PubMed ID: 23050811
[TBL] [Abstract][Full Text] [Related]
14. [Disseminated melanoma treatment].
Neidhardt-Bérard EM; Négrier S
Rev Prat; 2004 Jun; 54(11):1210-4. PubMed ID: 15496028
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
16. Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib.
Becker MR; Gaiser T
Int J Dermatol; 2009 Feb; 48(2):207-9. PubMed ID: 19200209
[No Abstract] [Full Text] [Related]
17. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
Bedikian AY; Johnson MM; Warneke CL; McIntyre S; Papadopoulos N; Hwu WJ; Kim K; Hwu P
J Immunotoxicol; 2008 Apr; 5(2):201-7. PubMed ID: 18569391
[TBL] [Abstract][Full Text] [Related]
18. [Linear porokeratosis].
Darrigade AS; Conte H; Ip Kan Fong H; Taïeb A; Jouary T
Ann Dermatol Venereol; 2011 Nov; 138(11):800-2. PubMed ID: 22078049
[No Abstract] [Full Text] [Related]
19. [Biological response modifiers in the treatment disseminated melanoma].
Akimov MA; Gershanovich ML
Vopr Onkol; 2002; 48(2):172-8. PubMed ID: 12227064
[No Abstract] [Full Text] [Related]
20. [Use of local magnitothermia in the treatment of patients with primary-confined skin melanoma].
Korovin SI; Tolstopiatov BA; Medinets IuR; Protsenko VV; Dedkov AG; Palivets AIu; Smakova MS
Lik Sprava; 2002; (1):129-33. PubMed ID: 11944360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
